Skip to content

Clinical effect of wet application of tripterygium wilfordii granules on psoriasis vulgaris

Clinical effect of wet application of tripterygium wilfordii granules on psoriasis vulgaris

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043505
Enrollment
Unknown
Registered
2021-02-21
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Interventions

Sponsors

Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The results were as follows: 1. The patients who met the diagnostic criteria of psoriasis vulgaris with skin lesion area less than or equal to 10% BSA tended to be aggregated; 2. Subjects who meet the diagnostic criteria of blood heat syndrome of traditional Chinese medicine; 3. Subjects aged >= 18 and <= 79 years, regardless of gender; 4. Patients with informed consent, signed informed consent, discussed through ethics committee, volunteered to receive treatment, observation and examination.

Exclusion criteria

Exclusion criteria: 1. Patients with only head and face lesions, patients with scattered lesions such as drip type, and patients with other active skin diseases may affect the condition evaluators; 2. Patients who received systemic research drugs, biological agents and immunosuppressants within 3 months; He had been treated with glucocorticoid and phototherapy within 2 weeks; 3. Patients in the period of severe uncontrollable local or systemic acute or chronic infection, patients with history of malignant tumor, patients with primary or secondary immunodeficiency and hypersensitivity, patients with severe systemic diseases, patients with severe mental history or family history, or other abnormal patients judged by researchers not suitable for this trial; 4. Patients who have undergone major surgery within 8 weeks or who will need such surgery during the study period; 5. Pregnant or lactating women; 6. Subjects with a history of alcohol, drug or drug abuse; 7. Subjects known to be allergic to Tripterygium wilfordii or calcipotriol, and subjects with calcium metabolism disorder; 8. For other reasons, those subjects that the researchers think are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
PASI;

Secondary

MeasureTime frame
BSA;VAS;

Countries

China

Contacts

Public ContactYang Yingyao

Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine

504168767@qq.com+86 15821358992

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026